TIDMHIK

RNS Number : 6672Q

Hikma Pharmaceuticals Plc

22 June 2020

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Extension of existing pledge by Darhold Limited 
       transaction               of 1,500,000 Ordinary Shares of 10 pence each 
                                 in Hikma Pharmaceuticals PLC in support of a 
                                 loan, in favour of J.P. Morgan (Suisse) SA. 
                                 Darhold Limited is defined as a Person Closely 
                                 Associated with the Executive Chairman, who 
                                 is a director and shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,500,000 
 d)   Aggregated information    Aggregated volume: 1,500,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   22 June 2020 
 f)   Place of the              Amman 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Extension of existing pledge by Darhold Limited 
       transaction               of 1,500,000 Ordinary Shares of 10 pence each 
                                 in Hikma Pharmaceuticals PLC in support of a 
                                 loan, in favour of J.P. Morgan (Suisse) SA. 
                                 Darhold Limited is defined as a Person Closely 
                                 Associated with the Executive Vice Chairman, 
                                 who is a director and shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,500,000 
 d)   Aggregated information    Aggregated volume: 1,500,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   22 June 2020 
 f)   Place of the              Amman 
       transaction 
 

Mohammed 'Ali' Al-Husry

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mohammed 'Ali' Al-Husry 
 2    Reason for the notification 
 a)   Position/status           Non-Executive Director 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Extension of existing pledge by Darhold Limited 
       transaction               of 1,500,000 Ordinary Shares of 10 pence each 
                                 in Hikma Pharmaceuticals PLC in support of a 
                                 loan, in favour of J.P. Morgan (Suisse) SA. 
                                 Darhold Limited is defined as a Person Closely 
                                 Associated with the Non-Executive Director, 
                                 who is a director and shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,500,000 
 d)   Aggregated information    Aggregated volume: 1,500,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   22 June 2020 
 f)   Place of the              Amman 
       transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBGGDLGDDDGGD

(END) Dow Jones Newswires

June 22, 2020 06:22 ET (10:22 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Ott 2020 a Nov 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Nov 2019 a Nov 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals